series-a
Stage
2
Investors
About
Hesperos develops physiologically realistic human-on-a-chip multi-organ in vitro platforms that model human physiology and disease for applications in drug discovery, safety testing, and therapeutic development, reducing reliance on animal testing.
Explore Hesperos's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.